Gabriela de Carvalho Kraemer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gabriela de Carvalho Kraemer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Suzana Nesi França
Graduate Program in Child and Adolescent Health, Federal University of Parana, Curitiba 80060-900, PR, Brazil
3 shared publications - Adriane Cardoso-Demartini
Setor de Endocrinologia Pediátrica Professor Romolo Sandrini, Departamento de Pediatria do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brasil
2 shared publications - Luiz De Lacerda
Department of Pediatrics, Federal University of Parana 1
2 shared publications - Rosana Marques Pereira
Setor de Endocrinologia Pediátrica Professor Romolo Sandrini, Departamento de Pediatria do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brasil
2 shared publications - Adriana Koliski
Pediatric Intensive Care Unit, Complexo Hospital de Clínicas da Universidade Federal do Paraná, Brazil
1 shared publication - Aline Scheidemantel
Setor de Endocrinologia Pediátrica Professor Romolo Sandrini, Departamento de Pediatria do Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (1) , 1-9
Adult height of children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analogs in Southern Brazil
Objective: To evaluate adult height and identify the factors contributing to its achievement in patients born small for gestational age (SGA) treated with recombinant human growth hormone (rhGH). Subjects and methods: This retrospective study includes data of SGA children treated at a pediatric endocrinology center. Inclusion criteria were SGA birth (birth length and/or weight < -1.28 standard deviation score (SDS), absence of catch-up growth by the age of four years, rhGH treatment for more than 12 months, and recorded [...] ABSTRACT Objective: To evaluate adult height and identify the factors contributing to its achievement in patients born small for gestational age (SGA) treated with recombinant human growth hormone (rhGH). Subjects and methods: This retrospective study includes data of SGA children treated at a pediatric endocrinology center. Inclusion criteria were SGA birth (birth length and/or weight < -1.28 standard deviation score (SDS), absence of catch-up growth by the age of four years, rhGH treatment for more than 12 months, and recorded
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (1) , 1-9
Open AccessAdult height of children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analogs in Southern Brazil
Objective: To evaluate adult height and identify the factors contributing to its achievement in patients born small for gestational age (SGA) treated with recombinant human growth hormone (rhGH). Subjects and methods: This retrospective study includes data of SGA children treated at a pediatric endocrinology center. Inclusion criteria were SGA birth (birth length and/or weight < -1.28 standard deviation score (SDS), absence of catch-up growth by the age of four years, rhGH treatment for more than 12 months, and recorded [...] ABSTRACT Objective: To evaluate adult height and identify the factors contributing to its achievement in patients born small for gestational age (SGA) treated with recombinant human growth hormone (rhGH). Subjects and methods: This retrospective study includes data of SGA children treated at a pediatric endocrinology center. Inclusion criteria were SGA birth (birth length and/or weight < -1.28 standard deviation score (SDS), absence of catch-up growth by the age of four years, rhGH treatment for more than 12 months, and recorded
- Open Access
- 20 April 2023
- Published by Elsevier in Jornal de Pediatria
- Vol. 99 (5) , 478-484
Cognitive outcome of 458 children over 25 years of neonatal screening for congenital hypothyroidism
- 20 April 2023
- Published by Elsevier in Jornal de Pediatria
- Vol. 99 (5) , 478-484
Open AccessCognitive outcome of 458 children over 25 years of neonatal screening for congenital hypothyroidism
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 38, e2018204
DIABETIC KETOACIDOSIS AS THE INITIAL PRESENTATION OF TYPE 1 DIABETES IN CHILDREN AND ADOLESCENTS: EPIDEMIOLOGICAL STUDY IN SOUTHERN BRAZIL
Objective: To analyze the variables associated with the presence of diabetic ketoacidosis in type 1 diabetes mellitus (T1DM) diagnosis and its impact on the progression of the disease. Methods: We reviewed the records of 274 children and adolescents under 15 years, followed in a Pediatric Endocrinology clinic of a university hospital in Curitiba-PR. They had their first appointment between January 2005 and April 2015. Results: Most patients received their T1DM diagnosis during a diabetic ketoacidosis episode. The associated factors were: lower age and greater number of visits to a physician’s office prior to diagnosis; diabetic ketoacidosis was less frequent in patients who had siblings with T1DM and those diagnosed at the first appointment. Nausea and vomiting, abdominal pain, tachydyspnea, and altered level of consciousness were more common in the diabetic ketoacidosis group. There was no association with socioeconomic status, duration of symptoms before diagnosis, and length of the honeymoon period. Conclusions: Prospective studies are necessary to better define the impact of these factors on diagnosis and disease control. Campaigns to raise awareness among health professionals and the general population are essential to promote early diagnosis and proper treatment of diabetes mellitus in children and adolescents.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 38, e2018204
Open AccessDIABETIC KETOACIDOSIS AS THE INITIAL PRESENTATION OF TYPE 1 DIABETES IN CHILDREN AND ADOLESCENTS: EPIDEMIOLOGICAL STUDY IN SOUTHERN BRAZIL
Objective: To analyze the variables associated with the presence of diabetic ketoacidosis in type 1 diabetes mellitus (T1DM) diagnosis and its impact on the progression of the disease. Methods: We reviewed the records of 274 children and adolescents under 15 years, followed in a Pediatric Endocrinology clinic of a university hospital in Curitiba-PR. They had their first appointment between January 2005 and April 2015. Results: Most patients received their T1DM diagnosis during a diabetic ketoacidosis episode. The associated factors were: lower age and greater number of visits to a physician’s office prior to diagnosis; diabetic ketoacidosis was less frequent in patients who had siblings with T1DM and those diagnosed at the first appointment. Nausea and vomiting, abdominal pain, tachydyspnea, and altered level of consciousness were more common in the diabetic ketoacidosis group. There was no association with socioeconomic status, duration of symptoms before diagnosis, and length of the honeymoon period. Conclusions: Prospective studies are necessary to better define the impact of these factors on diagnosis and disease control. Campaigns to raise awareness among health professionals and the general population are essential to promote early diagnosis and proper treatment of diabetes mellitus in children and adolescents.